Evolent Health Inc (EVH) Stock Analysis
Verdict: AVOID
Extreme undervaluation at 0.27x sales reflects a distressed balance sheet; survival depends on 2027-2029 EPS recovery vs debt load.
Investment score: 38/100
Analysis as of
Is Evolent Health Inc stock worth reviewing? The TradeMates thesis
The model views EVH as a high-risk distressed asset. Despite positive analyst sentiment and a massive insider buy signal, the 2.49 Debt/Equity ratio and consistent GAAP losses make it a gamble on 2027 profitability rather than a sound investment today.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 20/100 (weight 15%)
- Technical Momentum: 55/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 75/100 (weight 10%)
- Analyst Consensus: 70/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
Evolent Health Inc opportunities and risks
What speaks for EVH
- Drastic Undervaluation on Sales Basis
What speaks against EVH
- Solvency and Debt Service Risk
Peers and competitors
- CERT
- HSTM
- PHR
- MDRX
- CTEV
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| EVH | n/a | 0.3x | n/a | 14.1% | -26.3% | 0.3% |
| CERT | n/a | 2.0x | 9.7x | 58.1% | -3.6% | 10.7% |
| HSTM | 38.1x | 2.4x | 10.1x | 64.9% | 6.4% | 8.1% |
| PHR | 58.6x | 1.1x | 13.4x | 65.8% | 1.9% | 13.4% |
| MDRX | n/a | 1.4x | 10.6x | 52.5% | -14.7% | 9.8% |
| CTEV | n/a | 0.5x | 9.8x | 61.1% | -29.3% | -8.0% |
| Peer median | n/a | 1.4x | 10.1x | 61.1% | -3.6% | 9.8% |
Frequently asked questions about Evolent Health Inc (EVH)
Is EVH stock a good investment?
The TradeMates model rates Evolent Health Inc as AVOID with an investment score of 38/100. The model views EVH as a high-risk distressed asset. Despite positive analyst sentiment and a massive insider buy signal, the 2.49 Debt/Equity ratio and consistent GAAP losses make it a gamble on 2027 profitability rather than a sound investment today. This is algorithmic model output, not personal investment advice.
Is EVH stock a buy?
The TradeMates model verdict for EVH is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.